Ann: New positive interim data in Phase 2 study of SNT-5505, page-14

  1. 4 Posts.
    lightbulb Created with Sketch. 1

    "It’s sad to say those who have been on it for 5 yrs are beyond helping."

    This may be true in general, however, if I'm not mistaken - the second strongest improvement seen in TSS50 was in a patient that had been on it for 5yrs+ which, to be fair - may well represent an outlier. One 5+ yr patient also achieved SVR25 (possibly the same patient). I'm not a scientist or medical professional, so I don't know... but it may be possible that those who are 5+yrs on treatment continue to improve past the year mark on SNT-5505 (assuming they survive long enough). I certainly hope so anyway...


 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
5.7¢
Change
-0.010(14.9%)
Mkt cap ! $92.60M
Open High Low Value Volume
6.7¢ 6.7¢ 5.5¢ $569.7K 9.664M

Buyers (Bids)

No. Vol. Price($)
1 5000 5.6¢
 

Sellers (Offers)

Price($) Vol. No.
5.7¢ 468564 2
View Market Depth
Last trade - 16.10pm 16/06/2025 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.